Skip to main content
Erschienen in: Psychiatric Quarterly 3/2016

Open Access 08.12.2015 | Original Paper

Can Psychological, Social and Demographical Factors Predict Clinical Characteristics Symptomatology of Bipolar Affective Disorder and Schizophrenia?

verfasst von: Malgorzata Maciukiewicz, PhD, Joanna Pawlak, PhD, MD, Pawel Kapelski, PhD, MD, Magdalena Łabędzka, MD, Maria Skibinska, PhD, Dorota Zaremba, Anna Leszczynska-Rodziewicz, PhD, MD, Monika Dmitrzak-Weglarz, PhD, Joanna Hauser, PhD, MD

Erschienen in: Psychiatric Quarterly | Ausgabe 3/2016

Abstract

Schizophrenia (SCH) is a complex, psychiatric disorder affecting 1 % of population. Its clinical phenotype is heterogeneous with delusions, hallucinations, depression, disorganized behaviour and negative symptoms. Bipolar affective disorder (BD) refers to periodic changes in mood and activity from depression to mania. It affects 0.5–1.5 % of population. Two types of disorder (type I and type II) are distinguished by severity of mania episodes. In our analysis, we aimed to check if clinical and demographical characteristics of the sample are predictors of symptom dimensions occurrence in BD and SCH cases. We included total sample of 443 bipolar and 439 schizophrenia patients. Diagnosis was based on DSM-IV criteria using Structured Clinical Interview for DSM-IV. We applied regression models to analyse associations between clinical and demographical traits from OPCRIT and symptom dimensions. We used previously computed dimensions of schizophrenia and bipolar affective disorder as quantitative traits for regression models. Male gender seemed protective factor for depression dimension in schizophrenia and bipolar disorder sample. Presence of definite psychosocial stressor prior disease seemed risk factor for depressive and suicidal domain in BD and SCH. OPCRIT items describing premorbid functioning seemed related with depression, positive and disorganised dimensions in schizophrenia and psychotic in BD. We proved clinical and demographical characteristics of the sample are predictors of symptom dimensions of schizophrenia and bipolar disorder. We also saw relation between clinical dimensions and course of disorder and impairment during disorder.

Background

Schizophrenia (SCH) is a complex, psychiatric disorder with a mean lifetime morbid risk 1 % [1]. Its clinical phenotype is heterogeneous with delusions, hallucinations, depression, bizarre or disorganized behaviour and negative symptoms. Depressive episodes are also observed during SCH course [2]. Schizophrenia is influenced by both genetic and environmental factors [3]. Its exact etiology is still undescribed, thus Riley [4] suggested it is rather genetically mediated than genetically determined (H = 0.8). There are several environmental risk factors of schizophrenia, including: premature birth and low birth weight [5], maternal infections during pregnancy [6], hypoxia during neurodevelopment [7], seasonality of birth [8]. There are also psychological risk factors, including family instability and trauma during childhood [9].
Bipolar affective disorder (BD) refers to periodic changes in mood and activity from depression to mania. It affects 1 % of population. Two types of disorder (type I and type II) are distinguished by severity of mania episodes [10]. Mixed states are also observed. Psychotic symptoms are observed in some cases [11]. Family history of bipolar disorder is important risk factor [12]. As in schizophrenia, environmental risk factors of disorder are known. Dysfunctional interactions among family members increase the risk [13].
Schizophrenia and BD are both complex in terms of both clinical and genetic picture. Thus many factor analysis studies aimed to find clinical dimensions. Depressive, positive, negative, excitement and disorganised domains were detected in SCH sample, whereas depressive, excitement and psychotic appeared for BD [1418]. Potentially useful strategy is to use previously computed factor structure to seek for association with pre-morbid risk factors [15].
Both disorders (SCH and BD) are characterised by substantial genetic overlap. The genetic correlation coefficient equalled 0.6. Results from twin and adoption studies suggests overlap with schizoaffective disorder as well [19]. The large clinical overlap between schizophrenia and bipolar affective disorder is also known [20, 21].
In our study, we investigated if clinical and demographical characteristics of the sample (e.g. age at onset, duration of illness, sex) are predictors of symptom dimensions. Clinical dimensions describe disorder diversity and severity. We analysed if/how socio-demographical and clinical characteristics influence symptomatology of SCH and BD. To achieve our goal, we applied previously computed factor structure [14] as quantitative trait for regression models.

Sample Analysed

The sample comprised 892 bipolar disorder (n = 443) and schizophrenia (n = 449) patients. Diagnosis was based on DSM-IV criteria using Structured Clinical Interview for DSM-IV (SCID) [22]. We collected data about familial burden of the psychiatric disorders where possible. Lifetime perspective of symptoms was based on OPCRIT [23] checklist.
The average age at onset of BD individuals was 30.62 (SD = 11.17), whereas in schizophrenia cases 23.4 (SD = 6.59). Longer duration of illness appeared for SCH patients (22.25; SD = 21) in comparison with BD ones (19.37; SD = 14.83). Majority of patients were employed before onset of disorder (53 % in SCH and 83 % in BD).
All subjects were inpatients from Wielkopolska region of Poland. Patients gave written consent for the study after being informed about its details. Local Bioethics Committee approved the study. Sample characteristics is depicted in the Table 1.
Table 1
Sample characteristics. NA’s (“not available”) refers to situation when there are absences in OPCRIT items
 
Schizophrenia (n = 439)
Bipolar affective disorder (n = 443)
Sex
Female: 224 (51 %)
Female: 252 (57 %)
Male: 215 (49 %)
Male: 191 (43 %)
Age at onset
Mean: 23.08
Mean: 30.62
Min: 5.0
Min: 10.0
Max: 52.0
Max: 63.0
SD: 6.59
SD: 11.17
Family history of schizophrenia
Absent: 346 (79 %)
Absent: 409 (93 %)
Present: 81 (18 %)
Present: 24 (5 %)
NAs: 12 (3 %)
NAs: 10 (2 %)
Family history of other psychiatric disorders
Absent: 307 (70 %)
Absent: 216 (49 %)
Present: 108 (25 %)
Present: 221 (50 %)
NAs: 12 (5 %)
NAs: 6 (1 %)
Marital status
Married: 107 (24 %)
Maried: 307 (69 %)
Single: 330 (75.8 %)
Single: 135 (30 %)
NAs: 2 (0.2 %)
NAs: 1 (1 %)
Employment status at onsent
Employed: 228 (52 %)
Employed: 373 (84 %)
Unemployed: 198 (45 %)
Unemployed: 63 (14 %)
NAs: 13 (3 %)
NAs: 7 (2 %)
Definite psychosocial stressor prior to onset
Absent: 338 (77 %)
Absent: 243 (55 %)
Present: 89 (20 %)
Present: 162 (36 %)
NAs: 12 (3 %)
NAs: 33 (9 %)
Average duration of episode in weeks
Mean: 20.99
Mean: 19.37
Min: 1
Min: 2
Max: 240.00
Max: 156.00
SD: 21
SD: 14.83

Statistical Analysis

We applied Poisson regression models to detect relations between symptom dimensions and social/demographic characteristics. Previously described dimensions worked as quantitative dependent variable [14], thus we used Poisson instead of logistic regression. We defined quantitative trait (symptom dimension) as a sum of appropriate OPCRIT ratings. Item composition of particular domains is shown in Table 2. The high score of dimension (for example depressive) means, that most items generating domain ratings exceeding 0. It is not identical with severe depression identified by clinical terms.
Table 2
Previously described dimensional structure of schizophrenia and bipolar affective disorder [14]
 
Dimension
OPCRIT items
Schizophrenia
Depression (main)
Slowed activity, loss of energy/tiredness, dysphoria, loss of pleasure, altered libido, suicidal ideation
Appetite disturbances
Poor appetite, weight loss
Suicidal
Excessive self reproach, delusions of guilt, nihilistic delusions
Excitment
Excessive activity, reckless activity, distractibility, reduced need for sleep, agitated activity, pressured speech, thoughts racing, elevated mood, increased sociability
Atypical depression
Increased appetite, weight gain
Disorganised
Speech difficult to understand, incoherent, positive formal thought disorder, inappropriate affect
Negative
Restricted affect, blunted affect
Psychotic
Relationship between psychotic and affective symptoms, widespread delusions, primary delusions perception, other primary delusions
Positive (first rank symptoms) 1
Delusions of influence, delusions of passivity, thought insertion, thought withdrawal, thought broadcast, thought echo
Positive (first rank symptoms) 2
Delusions and hallucinations last for 1 week, persecutory/jealous delusions and hallucinations, third person auditory hallucinations, running commentary voices, abusive/accusatory/persecutory voices
Bipolar affective disorder
Depression (main)
Slowed activity, loss of energy/tiredness, dysphoria, diurnal variation, loss of pleasure, altered libido, poor concentration, excessive self reproach, suicidal ideation
Appetite disturbances
Poor appetite, weight loss
Atypical depression
Increased appetite, weight gain, excessive sleep
Sleep disturbances
Middle insomnia (broken sleep), early morning waking, poor appetite
Psychotic
Relationship between psychotic and affective symptoms, persecutory delusions, grandiose delusions, widespread delusions
Excitement
Excessive activity, reckless activity, distractibility, reduced need for sleep, pressured speech, thoughts racing, elevated mood
For BD, we built five models, basing on information collected: (1) affective disorders in a family, bipolar disorder in the family and other disorders in a family (first and second degree relatives); (2) premorbid personality disorder, marital status, employment at onset, work adjustment, premorbid social adjustment and definite psychological stressor prior onset; (3) age at onset: early (childhood and adolescence) and late (adulthood) and sex. Similar to Goldstein, we treated onset when 19 and more as adulthood and called it late [24]. In case of schizophrenia sample we checked following models: (1) gender and age at onset. Schizophrenia, as other neuropsychiatric illnesses, starts typically in late adolescence [25]. Thus, we treated age at onset 18 and earlier as early and onset later than 19 as late; (2) premorbid personality disorder, marital status, employment at onset, poor work adjustment, premorbid social adjustment and definite psychological stressor prior onset; (3) family history of schizophrenia, family history of other psychiatric disorders.
At the final stage, we used clinical dimension to predict course and impairment/incapacity during illness. Course of disorder and impairment/incapacity during disorder are measured by OPCRIT variables. Course (scored 1–5) is described as: single episode with good recovery (1); multiple episodes with good recovery (2); multiple episodes with partial recovery (3); continuous chronic illness (4); continuous chronic illness with deterioration (5). When impairment/incapacity is measured (scored 0–3) it is reported as: no impairment (0); subjective impairment at work, school, or in social functioning (1); impairment in major life role with definite reduction in productivity and/or criticism has been received (2); no function at all in major life role for more than 2 days, or in patient treatment has been required or active psychotic symptoms such as delusions or hallucinations have occurred (3).
All computations were performed using R environment [26].

Results

Regression Models of Bipolar Sample

We got statistically significant models for depression and psychotic domains. Results are presented in Table 3.
Table 3
Prediction of dimension severity based on social and demographic data
Item
Symptom dimension
Schizophrenia
Bipolar disorder
OR
CI (2.5 %;97.5 %)
p
OR
CI (2.5 %;97.5 %)
p
Sex male
Main depression
0.922
0.863;0.985
0.016
0.931
0.888;0.977
0.004
Psychotic
   
1.529
1.331;1.755
1.76E-009
Late age at onset
Main depression
0.745
0.692;0.802
4.92E-15
   
Psychotic
   
0.78
0.659;0.930
0.005
Premorbid personality disorder present
Main depression
1.275
1.143;1.422
0.0006
NS
NS
NS
Excitement
0.535
0.373;0.768
0.001
   
Suicidal
1.455
1.070;1.979
0.017
   
Positive 1
0.645
0.493;0.844
0.001
   
Positive 2
0.703
0.557;0.888
0.003
   
Definite psychosocial stressor prior to onset present
Excitement
1.360
1.147;1.613
0.0004
   
Suicidal
1.490
1.199;1.853
0.0003
   
Main depression
1.106
1.019;1.199
0.015
1.072
1.0197;1.127
0.006
Marital status single
Main depression
1.094
1.004;1.193
0.04
   
Psychotic
   
1.254
1.072;1.467
0.0047
Unemployed at onset
Positive 1
1.238
1.081;1.419
0.002
   
Psychotic
   
1.375
1.140;1.658
0.0008
Poor premorbid social adjustment no
Main depression
0.904
0.842;0.972
0.006
NS
NS
NS
Disorganised
0.839
0.735;0.958
0.0097
   
Family history of other psychiatric disorder present
Excitement
0.811
0.674;0.975
0.025
NS
NS
NS
Main depression
1.174
1.090;1.264
2.28E-05
   
NS abbreviates that no significant p value appeared for given variable
For depression domain, significant results appeared for models: (1) gender + age at onset; (2) premorbid personality disorder + marital status + employment at onset + work adjustment, premorbid social adjustment + definite psychological stressor prior onset. Male gender seemed protective factor for depression dimension (p = 0.004; OR 0.931). Presence of psychosocial stressor prior disease onset appeared as risk factor (p = 0.006; OR 1.072) for depression scores.
The same models (1) and (2) gave statistically important results for psychotic dimension. Late age at onset decreases its scores(p = 0.005; OR 0.783). Being unemployed before disease onset (p = 0.0008; OR 1.375) and having marital status “single” (p = 0.0047; OR 1.254) were risk factors.

Regression Models of Schizophrenia

For schizophrenia sample, we got statistically significant models for depression, positive, disorganised and excitement dimensions (see Table 2). We got strongest results for two models: (1) gender + age at onset and (2) premorbid personality disorder + marital status + employment at onset + work adjustment, premorbid social adjustment + definite psychological stressor prior onset.
Male gender (p = 0.016; OR 0.922) and late age at onset (p = 0.0; OR 0.745) seemed protective towards depressive dimension. Presence of premorbid personality disorder (p = 0.0006; OR 1.275) is a risk factor for higher depression scores. Absence of poor premorbid social adjustment decreases main depressive (p = 0.006; OR 0.904) and disorganization (p = 0.0097; OR 0.839) domains scores. Presence of psychiatric disorders in family seemed risk factor for depressive dimension (p = 2.28 × 10−5; OR 1.174). “Marital status” equalled “single” increased depression scores (p = 0.04; OR 1.094). We detected presence of psychological stressor prior to disorder onset (p = 0.003; OR 1.490) and premorbid personality disorder (p = 0.017; OR 1.455) as increasing suicidal dimension scores.
Presence of premorbid personality disorder diminishes excitement dimension scores (p = 0.001; OR 0.535). When premorbid psychological stressor prior to disease onset appeared, it increases excitement domain scores (p = 0.002, OR 1.023). Family history of other psychiatric disorder seemed protective towards schizophrenia’s excitement dimension scores (p = 0.025, OR 0.811).
Two positive psychotic subdimensions (described as positive 1 and positive 2) were related to premorbid functioning traits, i.e. presence of premorbid personality disorder and being unemployed at disease onset. Being unemployed seemed risk factor (p = 0.002, OR 1.238) of positive 1 subdimension. Presence of premorbid personality disorder was protective towards both positive 1 (p = 0.001, OR 0.645) and positive 2 dimension (p = 0.003; OR 0.703) domains.

Clinical Dimensions as Course Predictors

We observed relation of main depression dimension of bipolar disorder when use clinical dimensions as independent variables for regression equation. In the schizophrenia sample disorganised and excitement domains seemed important predictors of “impairment/incapacity during disorder” and “course of disorder” defined by OPCRIT checklist (see Table 4).
Table 4
Dimensions and prediction of disorder course and impairment/incapacity during disorders
Item
Schizophrenia
Bipolar disorder
OR
CI (2.5 %;97.5 %)
p
OR
CI (2.5 %;97.5 %)
p
Course of disorder
NS
NS
NS
1.023
1.009;1.039
0.002
Impairment incapacity during disorder
0.970;1.045
0.948;0.993;
1.003;1.088
0.010; 0.034
NS
NS
NS
NS abbreviates that no significant model obtained for given variable
Normal values indicated main depression symptom dimension; Bold values indicated suicidal symptom dimension; Italicised values indicated excitement symptom dimension; Underlined values indicated disorganised symptom dimension
Main depression domain seemed to increase risk of worse course of bipolar disorder (p = 0.02, OR 1.023). Course of disorder is defined by OPCRIT variables and coded numerically. “Worse course” means higher ratings in “course of disorder” item. In the schizophrenia sample, disorganization dimension was related with individual incapacity during disorder. When more disorganization symptoms appeared (higher score of domain), case’s incapacity increases (p = 0.034, OR 1.045). Excitement symptoms decrease (p = 0.01, OR 0.970) impairment and incapacity during disorder scores.

Discussion

Previous researchers proved relations between clinical and demographical traits and psychiatric disorders. In our study we use previously computed clinical dimensions of schizophrenia and bipolar disorder to seek for its relation with sample characteristics. We applied regression to detect and estimate relations among clinical dimension and clinical and demographical characteristics. We took no assumptions before conducting analyses. Our results are consistent with previous reports about relation of clinical and demographical characteristics and symptom dimensions of schizophrenia and bipolar disorder Marital status “single”, presence of family history of psychiatric disorders and premorbid personality disorders as risk factors for depressive domains higher scores. For suicidal subdimension presence of premorbid personality disorder and definite psychological stressor prior onset increase its scores. Male gender and later age at onset seemed protective towards higher depression scores in both schizophrenia and bipolar disorder. Higher depression scores in BD increase course of disorder scores. The relations between excitement domain and family history of psychiatric disorder, premorbid personality disorders and impairment/incapacity during disorder need further investigations.
Male gender seemed protective factor towards depression dimension high scores in schizophrenia and bipolar disorder samples. The observation is consistent with the fact that depression appears more often in woman and females are more likely to have depressive symptoms than males [27]. Other research groups confirmed female sex as significant predictor of depressive symptoms [28] and definite depression [29, 30]. Study by Rodgers group showed several depression subtypes appearance varies between males and females: anxiety disorders appeared in females with typical subtype, whereas males with severe typical type exhibited less masculine orientation. Severe atypical type associated with alcohol/drug dependence in female sample only [31].
For schizophrenia individuals age at onset as important predictor for depression dimension. Late age at onset seemed protective. Study by Faravelli group showed that risk of depression increase with age, but for females before menopause only [32]. Our results might differ, because we analysed not depressive disorder, but depression dimension in a schizophrenia. Recent study by Yasuda group proved late onset of SCH is characterised by more depressive symptoms [33]. Study by Emsley showed PANSS scores for depression and anxiety symptoms are more severe in females, first-episode individuals and ones with positive symptoms predominant. Depressive/anxiety scores on the other hand correlated with age, positive scores in PANSS and treatment outcome. Researchers also suggested depressive and anxiety scores presence may predict more favourable treatment outcome [34]. In our models “late age at onset” simply means “adult onset”, whereas “early age at onset” equals “adolescent age at onset”, which may be the reasons of some dissimilarities between our results and those obtained by other research groups. Our models suggest onset after adolescence is somehow protective towards depression symptoms. Further investigations in more detailed age groups might give more insight.
We found presence/absence of premorbid personality disorder as important predictor factor for depression, positive and excitement dimensions in schizophrenia. Premorbid personality disorder seemed to reduce scores of excitement and positive domains. We called our dimension excitement not (hypo)manic as its composed from items describing symptoms (excessive activity, reckless activity, distractibility, reduced need for sleep, agitated activity, pressured speech, thoughts racing, elevated mood and increase sociability). Possible explanation is presence of variables: “increase sociability” and “excessive activity” in excitement domain. Particular premorbid personality traits were related with specific dimensions: sociopathic traits with disorganization, schizotypal with positive dimension, whereas schizoid with negative dimensions and lesser with positive one. Manic traits were associated with disorganization dimension, negative dimension with schizoid, passive-dependent and schizotypic traits [35, 36]. As Peralta previously suggested, relation between premorbid personality disorders and schizophrenia dimensions should be interpreted in caution. It is often observed than premorbid disorders are diagnosed in retrospective [37]. We interpret our results carefully. Without more in depth analyses of premorbid disorders it is difficult to explain its relation with excitement and positive domains.
Presence of premorbid personality disorders and definite psychological stressor prior onset seemed risk factor of suicidal disturbances higher scores in schizophrenia cases. Suicidal behaviour is observed during schizophrenia and associated with depression. Suicide is important cause of death in schizophrenia: 10 % [38] or as suggested by others 4–5 % [39, 40] of schizophrenia patients commit suicide. Hopelessness, depression and greater insight into illness make important risk factor for suicidal behaviour, whereas being unmarried and male gender are associated with lower suicide risk [4143]. Clinical and demographical characteristics and known as risk or protective factors for suicide attempts. Early age at onset, poor premorbid social adjustment and childlessness in females were suggested as associated with suicide attempts in schizophrenia and affective disorders cases. Authors also stated demographical and clinical risk factors cannot be ignored [44]. Other studies however, showed that marital status, age and education do not influence suicidal ideation [45]. Good premorbid functioning as a single factor did not seem protective [46]. We described relation between presence of premorbid personality disorder and definite psychological stressor prior to disease with depressive symptoms associated with suicidal ideation (excessive self-reproach, delusions of guilt and nihilistic delusions), not suicidal behaviour. Probably interaction analyses of premorbid social adjustment and family burden of suicide attempts might produce more in depth models.
We saw relation between premorbid personality disorders and depression domain. Important aspect of depression in schizophrenia, is possible difficulty to distinguish from negative symptoms [47], which are typically present [48]. Premorbid personal disorders, depressive and negative manifestations might exhibit similar clinical picture. Apathy and lack of emotion are similar in both depressive and negative manifestations [49]. Depressive symptoms may be present in chronic phase and acute schizophrenia episode [34]. The fact that OPCRIT items describing premorbid social functioning increases severity of depressive manifestations only, might be results of difficulty mentioned. Early age at onset is associated with more severe negative symptoms of schizophrenia as [50] suggested. We saw late age at onset being protective towards depressive symptoms. However depressive and negative symptoms partly overlap in schizophrenia [51].
In schizophrenia sample, we observed presence of family history of psychiatric disorders, increases depressive dimension scores and decreases excitement dimension scores. It was described as risk of schizophrenia development [52]. We detected it is especially for depression dimension. Depressive symptoms are common in schizophrenia [51] and appear more frequent when there is family history of depression [53]. In our models “late” age at onset seemed protective towards depressive dimension in schizophrenia. No relation of family history and symptom dimensions appeared for bipolar sample.
In the last stage we checked if/how symptomatology of disease might be useful to predict disorder course and social functioning (described by OPCRIT variables “impairment/incapacity during disorder” and “course of disorder”). Higher scores of depression domain are associated with higher scores in course of disorder in BD sample. In case of schizophrenia, “disorganised” dimension seemed risk factor for worse impairment/incapacity during disorder. Excitement domain in SCH decrease impairment/incapacity, however this result are to interpret carefully. Correlation between depressive symptoms and performance and interpersonal behaviour was described. Mania symptoms seemed related with interpersonal friction [54]. Our bipolar models suggests association between high depression scores and high scores in course of disorder. Higher scores in course of disorder correspond to worse remission Partial remission with residual symptoms often happen in bipolar and unipolar disorder [55, 56]. In bipolar sample subsyndromal residual symptoms are related to last episode [57]. In the schizophrenia cases, “disorganised” dimension lead to poor social functioning during its course. Excitement dimension, however seemed protective. The reason might be excitement/mania domain definition. “Increased sociability”, “excessive activity” variables might work protective towards social isolation. Disorganization often present in schizophrenia has negative impact of social functioning. Recent study by Pandina proved clinically positive changes in disorganization symptoms enhances individual’s overall functioning [58].
Statistical methods enable researchers to detect and describe relationships. Pandina group applied regression models to analyse clinical symptoms and demographic characteristics influences cognitive improvement in schizophrenia and schizoaffective disorder [58]. Fiedorowicz group proved family history of bipolar disorders influence illness course, by increasing risk of hypomania/mania episodes frequency [59]. Recently Skokou and Gourzis checked how age at onset, sex, habitat, marital status and premorbid personality disorders influence paranoid schizophrenia. They proved urban birth, single status and avoidant personality traits are observed in young patients. Differences were more significant in male group. [60]. Detailed analyses of premorbid personality disorders and familial burden is needed to introduce more detailed models.
We proved clinical and demographical characteristics of the sample are predictors of symptom dimensions of schizophrenia and bipolar disorder. We also saw relation between clinical dimensions and course of disorder and impairment during disorder.

Acknowledgments

The study is supported by The National Science Centre, Poland, Grant Nos. NN 402 407 339, 402 467 140 and 2011/01/B/NZ5/02795.

Compliance with Ethical Standards

Conflicts of interest

All authors declared no conflicts of interest.

Ethical approval

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5).
Informed consent was obtained from all patients for being included in the study.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Neurologie & Psychiatrie

Kombi-Abonnement

Mit e.Med Neurologie & Psychiatrie erhalten Sie Zugang zu CME-Fortbildungen der Fachgebiete, den Premium-Inhalten der dazugehörigen Fachzeitschriften, inklusive einer gedruckten Zeitschrift Ihrer Wahl.

e.Med Psychiatrie

Kombi-Abonnement

Mit e.Med Psychiatrie erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Psychiatrie, den Premium-Inhalten der psychiatrischen Fachzeitschriften, inklusive einer gedruckten Zeitschrift Ihrer Wahl.

Literatur
1.
Zurück zum Zitat McGrath J, et al.: Schizophrenia: A concise overview of incidence, prevalence, and mortality. Epidemiologic Reviews 30:67–76, 2008CrossRefPubMed McGrath J, et al.: Schizophrenia: A concise overview of incidence, prevalence, and mortality. Epidemiologic Reviews 30:67–76, 2008CrossRefPubMed
2.
Zurück zum Zitat Jager M, et al.: Depression during an acute episode of schizophrenia or schizophreniform disorder and its impact on treatment response. Psychiatry Research 158(3):297–305, 2008CrossRefPubMed Jager M, et al.: Depression during an acute episode of schizophrenia or schizophreniform disorder and its impact on treatment response. Psychiatry Research 158(3):297–305, 2008CrossRefPubMed
3.
Zurück zum Zitat Sullivan PF, Kendler KS, Neale MC: Schizophrenia as a complex trait: Evidence from a meta-analysis of twin studies. Archives of General Psychiatry 60(12):1187–1192, 2003CrossRefPubMed Sullivan PF, Kendler KS, Neale MC: Schizophrenia as a complex trait: Evidence from a meta-analysis of twin studies. Archives of General Psychiatry 60(12):1187–1192, 2003CrossRefPubMed
4.
Zurück zum Zitat Riley B, Kendler KS: Molecular genetic studies of schizophrenia. European Journal of Human Genetics 14(6):669–680, 2006CrossRefPubMed Riley B, Kendler KS: Molecular genetic studies of schizophrenia. European Journal of Human Genetics 14(6):669–680, 2006CrossRefPubMed
5.
Zurück zum Zitat Kunugi H, Nanko S, Murray RM: Obstetric complications and schizophrenia: Prenatal underdevelopment and subsequent neurodevelopmental impairment. The British Journal of Psychiatry 40:s25–s29, 2001CrossRefPubMed Kunugi H, Nanko S, Murray RM: Obstetric complications and schizophrenia: Prenatal underdevelopment and subsequent neurodevelopmental impairment. The British Journal of Psychiatry 40:s25–s29, 2001CrossRefPubMed
6.
Zurück zum Zitat Oskvig DB, et al.: Maternal immune activation by LPS selectively alters specific gene expression profiles of interneuron migration and oxidative stress in the fetus without triggering a fetal immune response. Brain, Behavior, and Immunity 26(4):623–634, 2012CrossRefPubMedPubMedCentral Oskvig DB, et al.: Maternal immune activation by LPS selectively alters specific gene expression profiles of interneuron migration and oxidative stress in the fetus without triggering a fetal immune response. Brain, Behavior, and Immunity 26(4):623–634, 2012CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Schmidt-Kastner R, et al.: An environmental analysis of genes associated with schizophrenia: Hypoxia and vascular factors as interacting elements in the neurodevelopmental model. Molecular Psychiatry 17(12):1194–1205, 2012CrossRefPubMed Schmidt-Kastner R, et al.: An environmental analysis of genes associated with schizophrenia: Hypoxia and vascular factors as interacting elements in the neurodevelopmental model. Molecular Psychiatry 17(12):1194–1205, 2012CrossRefPubMed
8.
Zurück zum Zitat Torrey EF, et al.: Birth seasonality in bipolar disorder, schizophrenia, schizoaffective disorder and stillbirths. Schizophrenia Research 21(3):141–149, 1996CrossRefPubMed Torrey EF, et al.: Birth seasonality in bipolar disorder, schizophrenia, schizoaffective disorder and stillbirths. Schizophrenia Research 21(3):141–149, 1996CrossRefPubMed
9.
Zurück zum Zitat Husted JA, et al.: Early environmental exposures influence schizophrenia expression even in the presence of strong genetic predisposition. Schizophrenia Research 137(1–3):166–168, 2012CrossRefPubMedPubMedCentral Husted JA, et al.: Early environmental exposures influence schizophrenia expression even in the presence of strong genetic predisposition. Schizophrenia Research 137(1–3):166–168, 2012CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Craddock N, Sklar P: Genetics of bipolar disorder: Successful start to a long journey. Trends in Genetics 25(2):99–105, 2009CrossRefPubMed Craddock N, Sklar P: Genetics of bipolar disorder: Successful start to a long journey. Trends in Genetics 25(2):99–105, 2009CrossRefPubMed
11.
Zurück zum Zitat MacQueen GM, Hajek T, Alda M: The phenotypes of bipolar disorder: Relevance for genetic investigations. Molecular Psychiatry 10(9):811–826, 2005CrossRefPubMed MacQueen GM, Hajek T, Alda M: The phenotypes of bipolar disorder: Relevance for genetic investigations. Molecular Psychiatry 10(9):811–826, 2005CrossRefPubMed
12.
13.
Zurück zum Zitat Ferreira GS, et al.: Dysfunctional family environment in affected versus unaffected offspring of parents with bipolar disorder. Australian and New Zealand Journal of Psychiatry 47(11):1051–1057, 2013CrossRefPubMed Ferreira GS, et al.: Dysfunctional family environment in affected versus unaffected offspring of parents with bipolar disorder. Australian and New Zealand Journal of Psychiatry 47(11):1051–1057, 2013CrossRefPubMed
14.
Zurück zum Zitat Maciukiewicz M, et al.: Analysis of OPCRIT results indicate the presence of a novel ‘social functioning’ domain and complex structure of other dimensions in the Wielkopolska (Poland) population. Schizophrenia Research 138(2–3):223–232, 2012CrossRefPubMed Maciukiewicz M, et al.: Analysis of OPCRIT results indicate the presence of a novel ‘social functioning’ domain and complex structure of other dimensions in the Wielkopolska (Poland) population. Schizophrenia Research 138(2–3):223–232, 2012CrossRefPubMed
15.
Zurück zum Zitat Allardyce J, et al.: Do symptom dimensions or categorical diagnoses best discriminate between known risk factors for psychosis? Social Psychiatry and Psychiatric Epidemiology 42(6):429–437, 2007CrossRefPubMedPubMedCentral Allardyce J, et al.: Do symptom dimensions or categorical diagnoses best discriminate between known risk factors for psychosis? Social Psychiatry and Psychiatric Epidemiology 42(6):429–437, 2007CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Dikeos DG, et al.: Distribution of symptom dimensions across Kraepelinian divisions. British Journal of Psychiatry 189:346–353, 2006CrossRefPubMed Dikeos DG, et al.: Distribution of symptom dimensions across Kraepelinian divisions. British Journal of Psychiatry 189:346–353, 2006CrossRefPubMed
17.
Zurück zum Zitat Serretti A, Olgiati P: Dimensions of major psychoses: A confirmatory factor analysis of six competing models. Psychiatry Research 127(1–2):101–109, 2004CrossRefPubMed Serretti A, Olgiati P: Dimensions of major psychoses: A confirmatory factor analysis of six competing models. Psychiatry Research 127(1–2):101–109, 2004CrossRefPubMed
18.
Zurück zum Zitat Serretti A, et al.: Major psychoses symptomatology: Factor analysis of 2241 psychotic subjects. European Archives of Psychiatry and Clinical Neuroscience 251(4):193–198, 2001CrossRefPubMed Serretti A, et al.: Major psychoses symptomatology: Factor analysis of 2241 psychotic subjects. European Archives of Psychiatry and Clinical Neuroscience 251(4):193–198, 2001CrossRefPubMed
20.
Zurück zum Zitat Andreassen OA, et al.: Genetic pleiotropy between multiple sclerosis and schizophrenia but not bipolar disorder: Differential involvement of immune-related gene loci. Molecular Psychiatry 40(1):13–17, 2014. doi:10.1093/schbul/sbt168 Andreassen OA, et al.: Genetic pleiotropy between multiple sclerosis and schizophrenia but not bipolar disorder: Differential involvement of immune-related gene loci. Molecular Psychiatry 40(1):13–17, 2014. doi:10.​1093/​schbul/​sbt168
21.
Zurück zum Zitat Tamminga CA, et al.: Clinical phenotypes of psychosis in the bipolar-schizophrenia network on intermediate phenotypes (B-SNIP). American Journal of Psychiatry 170(11):1263–1274, 2013CrossRefPubMed Tamminga CA, et al.: Clinical phenotypes of psychosis in the bipolar-schizophrenia network on intermediate phenotypes (B-SNIP). American Journal of Psychiatry 170(11):1263–1274, 2013CrossRefPubMed
22.
Zurück zum Zitat First MB: User’s Guide for the Structured Clinical Interview for DSM-IV Axis II Personality Disorders: SCID-II. Washington, American Psychiatric Press, p. 91, 1997 First MB: User’s Guide for the Structured Clinical Interview for DSM-IV Axis II Personality Disorders: SCID-II. Washington, American Psychiatric Press, p. 91, 1997
23.
Zurück zum Zitat Craddock M, et al.: Concurrent validity of the OPCRIT diagnostic system. Comparison of OPCRIT diagnoses with consensus best-estimate lifetime diagnoses. British Journal of Psychiatry 169(1):58–63, 1996CrossRefPubMed Craddock M, et al.: Concurrent validity of the OPCRIT diagnostic system. Comparison of OPCRIT diagnoses with consensus best-estimate lifetime diagnoses. British Journal of Psychiatry 169(1):58–63, 1996CrossRefPubMed
24.
Zurück zum Zitat Goldstein BI, Levitt AJ: Further evidence for a developmental subtype of bipolar disorder defined by age at onset: Results from the national epidemiologic survey on alcohol and related conditions. American Journal of Psychiatry 163(9):1633–1636, 2006CrossRefPubMed Goldstein BI, Levitt AJ: Further evidence for a developmental subtype of bipolar disorder defined by age at onset: Results from the national epidemiologic survey on alcohol and related conditions. American Journal of Psychiatry 163(9):1633–1636, 2006CrossRefPubMed
25.
26.
Zurück zum Zitat Team RC: R: A Language and Environment for Statistical Computing. Vienna, R Foundation for Statistical Computing, 2013 Team RC: R: A Language and Environment for Statistical Computing. Vienna, R Foundation for Statistical Computing, 2013
27.
Zurück zum Zitat Craddock N, Forty L: Genetics of affective (mood) disorders. European Journal of Human Genetics 14(6):660–668, 2006CrossRefPubMed Craddock N, Forty L: Genetics of affective (mood) disorders. European Journal of Human Genetics 14(6):660–668, 2006CrossRefPubMed
28.
Zurück zum Zitat Kim E, et al.: A survey of depressive symptoms among South Korean adults after the Korean financial crisis of late 1997: Prevalence and correlates. Annals of Epidemiology 15(2):145–152, 2005CrossRefPubMed Kim E, et al.: A survey of depressive symptoms among South Korean adults after the Korean financial crisis of late 1997: Prevalence and correlates. Annals of Epidemiology 15(2):145–152, 2005CrossRefPubMed
29.
Zurück zum Zitat Oh DH, et al.: Prevalence and correlates of depressive symptoms in korean adults: Results of a 2009 korean community health survey. Journal of Korean Medical Science 28(1):128–135, 2013CrossRefPubMedPubMedCentral Oh DH, et al.: Prevalence and correlates of depressive symptoms in korean adults: Results of a 2009 korean community health survey. Journal of Korean Medical Science 28(1):128–135, 2013CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat St John PD, Montgomery PR: Marital status, partner satisfaction, and depressive symptoms in older men and women. Canadian Journal of Psychiatry 54(7):487–492, 2009 St John PD, Montgomery PR: Marital status, partner satisfaction, and depressive symptoms in older men and women. Canadian Journal of Psychiatry 54(7):487–492, 2009
32.
Zurück zum Zitat Faravelli C, et al.: Gender differences in depression and anxiety: The role of age. Psychiatry Research 210(3):1301–1303, 2013CrossRefPubMed Faravelli C, et al.: Gender differences in depression and anxiety: The role of age. Psychiatry Research 210(3):1301–1303, 2013CrossRefPubMed
33.
Zurück zum Zitat Yasuda M, et al.: Clinical features of late-onset schizophrenia in Japan: Comparison with early-onset cases. Psychogeriatrics 13(4):244–249, 2013CrossRefPubMed Yasuda M, et al.: Clinical features of late-onset schizophrenia in Japan: Comparison with early-onset cases. Psychogeriatrics 13(4):244–249, 2013CrossRefPubMed
34.
Zurück zum Zitat Emsley RA, et al.: Depressive and anxiety symptoms in patients with schizophrenia and schizophreniform disorder. Journal of Clinical Psychiatry 60(11):747–751, 1999CrossRefPubMed Emsley RA, et al.: Depressive and anxiety symptoms in patients with schizophrenia and schizophreniform disorder. Journal of Clinical Psychiatry 60(11):747–751, 1999CrossRefPubMed
35.
Zurück zum Zitat Cuesta MJ, Peralta V, Caro F: Premorbid personality in psychoses. Schizophrenia Bulletin 25(4):801–811, 1999CrossRefPubMed Cuesta MJ, Peralta V, Caro F: Premorbid personality in psychoses. Schizophrenia Bulletin 25(4):801–811, 1999CrossRefPubMed
36.
Zurück zum Zitat Cuesta MJ, et al.: Premorbid personality and psychopathological dimensions in first-episode psychosis. Schizophrenia Research 58(2–3):273–280, 2002CrossRefPubMed Cuesta MJ, et al.: Premorbid personality and psychopathological dimensions in first-episode psychosis. Schizophrenia Research 58(2–3):273–280, 2002CrossRefPubMed
37.
Zurück zum Zitat Peralta V, Cuesta MJ, de Leon J: Premorbid personality and positive and negative symptoms in schizophrenia. Acta Psychiatrica Scandinavica 84(4):336–339, 1991CrossRefPubMed Peralta V, Cuesta MJ, de Leon J: Premorbid personality and positive and negative symptoms in schizophrenia. Acta Psychiatrica Scandinavica 84(4):336–339, 1991CrossRefPubMed
38.
Zurück zum Zitat Caldwell CB, Gottesman II: Schizophrenics kill themselves too: A review of risk factors for suicide. Schizophrenia Bulletin 16(4):571–589, 1990 Caldwell CB, Gottesman II: Schizophrenics kill themselves too: A review of risk factors for suicide. Schizophrenia Bulletin 16(4):571–589, 1990
39.
Zurück zum Zitat Carlborg A, et al.: Suicide in schizophrenia. Expert Review of Neurotherapeutics 10(7):1153–1164, 2010CrossRefPubMed Carlborg A, et al.: Suicide in schizophrenia. Expert Review of Neurotherapeutics 10(7):1153–1164, 2010CrossRefPubMed
40.
Zurück zum Zitat Palmer BA, Pankratz VS, Bostwick JM: The lifetime risk of suicide in schizophrenia: A reexamination. Archives of General Psychiatry 62(3):247–253, 2005CrossRefPubMed Palmer BA, Pankratz VS, Bostwick JM: The lifetime risk of suicide in schizophrenia: A reexamination. Archives of General Psychiatry 62(3):247–253, 2005CrossRefPubMed
41.
Zurück zum Zitat Kao YC, Liu YP: Suicidal behavior and insight into illness among patients with schizophrenia spectrum disorders. Psychiatric Quarterly 82(3):207–220, 2011CrossRefPubMed Kao YC, Liu YP: Suicidal behavior and insight into illness among patients with schizophrenia spectrum disorders. Psychiatric Quarterly 82(3):207–220, 2011CrossRefPubMed
42.
Zurück zum Zitat Balhara YP, Verma R: Schizophrenia and suicide. East Asian Archives of Psychiatry 22(3):126–133, 2012PubMed Balhara YP, Verma R: Schizophrenia and suicide. East Asian Archives of Psychiatry 22(3):126–133, 2012PubMed
43.
Zurück zum Zitat Gomez-Duran EL, Martin-Fumado C, Hurtado-Ruiz G: Clinical and epidemiological aspects of suicide in patients with schizophrenia. Actas Esp Psiquiatr 40(6):333–345, 2012PubMed Gomez-Duran EL, Martin-Fumado C, Hurtado-Ruiz G: Clinical and epidemiological aspects of suicide in patients with schizophrenia. Actas Esp Psiquiatr 40(6):333–345, 2012PubMed
44.
Zurück zum Zitat Muller DJ, et al.: Suicide attempts in schizophrenia and affective disorders with relation to some specific demographical and clinical characteristics. European Psychiatry 20(1):65–69, 2005CrossRefPubMed Muller DJ, et al.: Suicide attempts in schizophrenia and affective disorders with relation to some specific demographical and clinical characteristics. European Psychiatry 20(1):65–69, 2005CrossRefPubMed
45.
Zurück zum Zitat Montross LP, et al.: Suicidal ideation and suicide attempts among middle-aged and older patients with schizophrenia spectrum disorders and concurrent subsyndromal depression. The Journal of Nervous Mental Disease 196(12):884–890, 2008CrossRefPubMed Montross LP, et al.: Suicidal ideation and suicide attempts among middle-aged and older patients with schizophrenia spectrum disorders and concurrent subsyndromal depression. The Journal of Nervous Mental Disease 196(12):884–890, 2008CrossRefPubMed
46.
Zurück zum Zitat Restifo K, Harkavy-Friedman JM, Shrout PE: Suicidal behavior in schizophrenia: A test of the demoralization hypothesis. The Journal of Nervous and Mental Disorder 197(3):147–153, 2009CrossRefPubMed Restifo K, Harkavy-Friedman JM, Shrout PE: Suicidal behavior in schizophrenia: A test of the demoralization hypothesis. The Journal of Nervous and Mental Disorder 197(3):147–153, 2009CrossRefPubMed
47.
Zurück zum Zitat Chiappelli J, et al.: Assessment of trait and state aspects of depression in schizophrenia. Schizophrenia Bulletin 40(1):132–142, 2014CrossRefPubMed Chiappelli J, et al.: Assessment of trait and state aspects of depression in schizophrenia. Schizophrenia Bulletin 40(1):132–142, 2014CrossRefPubMed
48.
Zurück zum Zitat Silveira C, Marques-Teixeira J, de Bastos-Leite AJ: More than one century of schizophrenia: An evolving perspective. Journal of Nervous and Mental Disorder 200(12):1054–1057, 2012CrossRefPubMed Silveira C, Marques-Teixeira J, de Bastos-Leite AJ: More than one century of schizophrenia: An evolving perspective. Journal of Nervous and Mental Disorder 200(12):1054–1057, 2012CrossRefPubMed
49.
Zurück zum Zitat Gozdzik-Zelazny A, Borecki L, Pokorski M: Depressive symptoms in schizophrenic patients. European Journal of Medical Research 16(12):549–552, 2011CrossRefPubMedPubMedCentral Gozdzik-Zelazny A, Borecki L, Pokorski M: Depressive symptoms in schizophrenic patients. European Journal of Medical Research 16(12):549–552, 2011CrossRefPubMedPubMedCentral
50.
Zurück zum Zitat Bellino S, et al.: Relationships of age at onset with clinical features and cognitive functions in a sample of schizophrenia patients. Journal of Clinical Psychiatry 65(7):908–914, 2004CrossRefPubMed Bellino S, et al.: Relationships of age at onset with clinical features and cognitive functions in a sample of schizophrenia patients. Journal of Clinical Psychiatry 65(7):908–914, 2004CrossRefPubMed
51.
Zurück zum Zitat Majadas S, et al.: Prevalence of depression and its relationship with other clinical characteristics in a sample of patients with stable schizophrenia. Comprehensive Psychiatry 53(2):145–151, 2012CrossRefPubMed Majadas S, et al.: Prevalence of depression and its relationship with other clinical characteristics in a sample of patients with stable schizophrenia. Comprehensive Psychiatry 53(2):145–151, 2012CrossRefPubMed
52.
Zurück zum Zitat Mortensen PB, Pedersen MG, Pedersen CB: Psychiatric family history and schizophrenia risk in Denmark: Which mental disorders are relevant? Psychological Medicine 40(2):201–210, 2010CrossRefPubMed Mortensen PB, Pedersen MG, Pedersen CB: Psychiatric family history and schizophrenia risk in Denmark: Which mental disorders are relevant? Psychological Medicine 40(2):201–210, 2010CrossRefPubMed
53.
Zurück zum Zitat Babinkostova Z, Stefanovski B: Family history in patients with schizophrenia and depressive symptoms. Prilozi 32(1):219–228, 2011PubMed Babinkostova Z, Stefanovski B: Family history in patients with schizophrenia and depressive symptoms. Prilozi 32(1):219–228, 2011PubMed
54.
Zurück zum Zitat Morriss R, et al.: Differential effects of depression and mania symptoms on social adjustment: Prospective study in bipolar disorder. Bipolar Disorder 15(1):80–91, 2013CrossRefPubMed Morriss R, et al.: Differential effects of depression and mania symptoms on social adjustment: Prospective study in bipolar disorder. Bipolar Disorder 15(1):80–91, 2013CrossRefPubMed
55.
Zurück zum Zitat Paykel ES: Partial remission, residual symptoms, and relapse in depression. Dialogues in Clinical Neuroscience 10(4):431–437, 2008PubMedPubMedCentral Paykel ES: Partial remission, residual symptoms, and relapse in depression. Dialogues in Clinical Neuroscience 10(4):431–437, 2008PubMedPubMedCentral
56.
Zurück zum Zitat Vieta E, et al.: Subsyndromal depressive symptoms in patients with bipolar and unipolar disorder during clinical remission. Journal of Affective Disorders 107(1–3):169–174, 2008CrossRefPubMed Vieta E, et al.: Subsyndromal depressive symptoms in patients with bipolar and unipolar disorder during clinical remission. Journal of Affective Disorders 107(1–3):169–174, 2008CrossRefPubMed
57.
Zurück zum Zitat Kaya E, Aydemir O, Selcuki D: Residual symptoms in bipolar disorder: The effect of the last episode after remission. Progress in Neuro-psychopharmacology and Biological Psychiatry 31(7):1387–1392, 2007CrossRefPubMed Kaya E, Aydemir O, Selcuki D: Residual symptoms in bipolar disorder: The effect of the last episode after remission. Progress in Neuro-psychopharmacology and Biological Psychiatry 31(7):1387–1392, 2007CrossRefPubMed
58.
Zurück zum Zitat Pandina G, et al.: Identification of clinically meaningful relationships among cognition, functionality, and symptoms in subjects with schizophrenia or schizoaffective disorder. Schizophrenia Research 143(2–3):312–318, 2013CrossRefPubMed Pandina G, et al.: Identification of clinically meaningful relationships among cognition, functionality, and symptoms in subjects with schizophrenia or schizoaffective disorder. Schizophrenia Research 143(2–3):312–318, 2013CrossRefPubMed
59.
Zurück zum Zitat Fiedorowicz JG, et al.: Course of illness following prospectively observed mania or hypomania in individuals presenting with unipolar depression. Bipolar Disorder 14(6):664–671, 2012CrossRefPubMedPubMedCentral Fiedorowicz JG, et al.: Course of illness following prospectively observed mania or hypomania in individuals presenting with unipolar depression. Bipolar Disorder 14(6):664–671, 2012CrossRefPubMedPubMedCentral
Metadaten
Titel
Can Psychological, Social and Demographical Factors Predict Clinical Characteristics Symptomatology of Bipolar Affective Disorder and Schizophrenia?
verfasst von
Malgorzata Maciukiewicz, PhD
Joanna Pawlak, PhD, MD
Pawel Kapelski, PhD, MD
Magdalena Łabędzka, MD
Maria Skibinska, PhD
Dorota Zaremba
Anna Leszczynska-Rodziewicz, PhD, MD
Monika Dmitrzak-Weglarz, PhD
Joanna Hauser, PhD, MD
Publikationsdatum
08.12.2015
Verlag
Springer US
Erschienen in
Psychiatric Quarterly / Ausgabe 3/2016
Print ISSN: 0033-2720
Elektronische ISSN: 1573-6709
DOI
https://doi.org/10.1007/s11126-015-9405-z

Weitere Artikel der Ausgabe 3/2016

Psychiatric Quarterly 3/2016 Zur Ausgabe

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.